Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Editorial

    Editorial

    Web AdminBy Web AdminDecember 24, 2021Updated:December 24, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    I.E. Cock1,2,*
    Editor-In-Chief
    1Centre for Planetary Health and food Security, Nathan Campus, Griffith University, Brisbane, Queensland, AUSTRALIA.
    2School of Natural Sciences, Nathan Campus, Griffith University, Brisbane, Queensland, AUSTRALIA.

    DOI: 10.5530/pc.2022.1.1

    Dear Readers and Authors,

    I am pleased to bring you Volume 12, Issue 1 of Pharmacognosy Communications. In this issue, we present a review on the uses of mucilage for industrial processes. We also present new research reports examining the antimalarial properties and phytochemistry of Streptomyces hygroscopicus, the antibacterial activity of the southern African plant Harpagophytum procumbens (commonly known as Devil’s claw) against bacterial gastrointestinal pathogens, as well as bacteruial triggers our some autoimmune inflammatory diseases. We also include a study reporting the lack of antibacterial activity for Lomandra hystrix extracts, as well as an educational case study.

    Our regular features are also continued in this issue. Two more high quality medicinal plant images are also included in this issue and a listing of upcoming conferences and meetings is also included. I encourage any conference organisers who would like to publicise their event to contact me with details so they can be included in future upcoming events sections of this journal. I look forward to bringing you the next issue of Pharmacognosy Communications in 3 months’ time. Keep submitting your quality research manuscripts and reviews and also consider becoming involved/submitting to the other sections (Janus Corner, Medicinal Plant Images etc.) of the journal. On behalf of the editorial board, we look forward to bringing you the next issue of Pharmacognosy Communications in 3 months’ time.

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up